Taurine: A particular aminoacid with multiple functions;La taurine: Un aminoacide particulier aux fonctions multiples

Annales Pharmaceutiques Francaises

Volumn 61, Issue 6, 2003, Pages 385-391

  Bidri, M ^a   Choay, P ^a  

^a NONE   (France)

Author keywords

"Conditionnally essential" aminoacid; Antioxidant; In vitro fertilization; Osmoregulation; Taurine

Indexed keywords

ANTIOXIDANT; BETA AMINO ACID; BILE ACID; CALCIUM; ESSENTIAL AMINO ACID; TAURINE;

ALCOHOLISM; AMINO ACID METABOLISM; ANTIOXIDANT ACTIVITY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CYSTIC FIBROSIS; DETOXIFICATION; EMBRYO DEVELOPMENT; FERTILIZATION; FERTILIZATION IN VITRO; GENITAL SYSTEM; HUMAN; LIVER DISEASE; MEMBRANE STABILIZATION; NEUROMODULATION; OSMOREGULATION; RETINA DEGENERATION; SHORT SURVEY; SPERMATOZOON CAPACITATION; SPERMATOZOON MOTILITY; XENOBIOTIC METABOLISM;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR PHYSIOLOGY; HUMANS; TAURINE;

EID: 0344823998     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (51)

1. Huxtable RJ. Physiological actions of taurine. Physiol rev 1992; 72: 101-63.
2. Hardison WG. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978; 75: 71-5.
3. Skare KL, Schnoes HK, De Luca HF. Biliary metabolites of all trans-retinoic acid in the rat: isolation and identification of a novel polar metabolite. Biochemistry 1982; 21: 3308-17.
4. Stapleton PP, O'Flaherty L, Redmond HP, Bouchier-Hayes DJ. Host defense-a role for the amino acid taurine? J Parenter Enteral Nutr 1998; 22: 42-8.
5. Sturman JA. Taurine in development. Physiol Rev 1993; 73: 119-47.
6. Worden JA, Stipanuk MH. A comparison by species, age and sex of cysteinesulfinate decarboxylase activity and taurine concentration in liver and brain of animals. Comp Biochem Physiol 1985; 82: 233-9.
7. Dillon JC. La taurine. Cah Nutr Diét 1991; 26: 412-5.
8. Birdsall TC. Therapeutic applications of taurine. Altern Med Rev 1998; 3: 128-36.
9. Koyama I, Nakamura T, Ogasawara M, Nemoto M, Yoshida T. The protective effect of taurine on the biomembrane against damage produced by the oxygen radical. Adv Exp Med Biol 1992; 315: 355-9.
10. Schaffer S, Takahashi K, Azuma J. Role of osmoregulation in the actions of taurine. Amino Acids 2000; 19: 527-46.
11. Dutton GR, Barry M, Simmons ML, Philibert RA. Astrocyte taurine. Ann N Y Acad Sci 1991; 633: 489-500.
12. Takahashi K, Harada H, Schaffer SW, Azuma J. Effect of taurine on intracellular calcium dynamics of cultured myocardial cells during the calcium paradox. Adv Exp Med Biol 1992; 315: 153-61.
13. Thomas EL, Grisham MB, Melton DF, Jefferson MM. Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. J Biol Chem 1985; 260: 3321-9.
14. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of taurine, hypotaurine and their metabolic precursors. Biochem J 1988; 256: 251-5.
15. Zhang W, Chen C, Dong B, Lu D, Chen D. The role of taurine as hydroxyl radical inhibitor and its effect on lipid peroxidation in selenite cataract. Zhonghua Yan Ke Za Zhi 2002; 38: 157-60.
16. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 2002; 163: 79-7.
17. Pasantes-Morales H, Cruz C. Taurine and hypotaurine inhibit light-induced lipid peroxidation and protect rod outer segment structure. Brain Res 1985; 330: 154-7.
18. Yan CC, Huxtable RJ. Effects of taurine and guanidinoethane sulfonate on toxicity of the pyrrolizidine alkaloid monocrotaline. Biochem Pharmacol 1996; 51: 321-9.
19. Waters E, Wang JH, Redmond HP, Wu QD, Kay E, Bouchier-Hayes D. Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am J Physiol Gastrointest Liver Physiol 2001; 280: G1274-G1279
20. Vohra BP, Hui X. Taurine protects against carbon tetrachloride toxicity in the cultured neurons and in vivo. Arch Physiol Biochem 2001; 109: 90-4.
21. Alvarez JG, Storey BT. Taurine, hypotaurine, epinephrine and albumin inhibit lipid peroxidation in rabitt spermatozoa and protect against loss motility. Biol Reprod 1983; 29: 548-55.
22. Gurer H, Ozgunes H, Saygin E, Ercal N. Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ Contam Toxicol 2001; 41: 397-402.
23. Mizushima S, Nara Y, Sawamura M, Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Bio, 1996; 403: 615-22.
24. Matsuno H, Uematsu T, Niwa M, Kozawa O, Nagashima S, Kohno K et al. Pharmacokinetic and pharmacodynamic properties of a new thromboxane receptor antagonist (Z-335) after single and multiple oral administrations to healthy volunteers. J Clin Pharmacol 2002; 42: 782-90.
25. Kolis SJ, Postma EJ, William TH, Sasso GJ. Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation. Drug Metab Dispos 1986; 14: 465-70.
26. Smith LJ, Lacaille F, Lepage G, Ronco N, Lamarre A, Roy CC. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial. Am J Dis Child 1991; 145: 1401-4.
27. Huxtable RJ, Chubb J, Azari J. Physiological and experimental regulation of taurine content in the heart. Fed Prod 1980; 39: 2685-90.
28. Mal'Chikova LS, Elizarova EP. Effect of swimming on the uptake and content of taurine in the heart. Kardiologiia 1978; 18: 82-6.
29. Suleiman MS. New concept in the cardioprotective action of magnesium and taurine during the calcium paradox and ischaemia of the heart. Magnes Res 1994; 7: 295-312.
30. Satoh H, Sperelakis N. Review of some actions of taurine on ion channels of cardiac muscle cells and others. Gen Pharmacol 1998; 30: 451-63.
31. Sole MJ, Jeejeebhoy KN. Conditioned nutritional requirements and the pathogenesis and treatment of myocardial failure. Curr Opin Clin Nutr Metab Care 2000; 6: 417-24.
32. Azuma J, Sawamura A, Awata N, Ohta H, Hamaguchi T, Harada H et al. Therapeutic effect of taurine in congestive heart faillure: a double-blind crossover trial. Clin Cardiol 1985; 8: 276-82.
33. Okada M, Okuma Y, Osumi Y, Nishihara M, Yokotani K, Ueno H. Neurotransmitter contents in the retina of RCS rat. Graefes Arch Clin Exp Ophthalmol 2000; 238: 998-1001.
34. Militante JD, Lombardini JB. Taurine: evidence of physiological function in the retina. Nutr Neurosci 2002; 5: 75-90.
35. Lombardini JB. Taurine: retinal function. Brain Res Brain Res Rev 1991; 16: 151-69.
36. Sturman JA. Nutritional taurine and central nervous system development. Ann NY Acad Sci 1986; 477: 196-213.
37. Uma SM, Satapathy M, Sitaramayya A. Decreased plasma taurine levels in retinitis pigmentosa. Biochem Med 1983; 30: 49-52.
38. Voaden MJ, Hussain AA, Chan IP. Studies on retinitis pigmentosa in man. I. Taurine and blood platelets. Br J Ophthalmol 1982; 66: 771-5.
39. Reccia R, Pignalosa B, Grasso A, Campanella G. Taurine treatment in retinitis pigmentosa. Acta Neurol 1980; 18: 132-6.
40. Geggel HS, Ament ME, Heckenlively JR, Martin DA, Kopple JD. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl JMed 1985; 312: 142-6.
41. Trachtman H, Futterweit S, del Pizzo R. Taurine and osmoregulation. IV. Cerebral taurine transport is increased in rats with hypernatremic dehydration. Pediatr Res 1992; 32: 118-24.
42. Airaksinen EM, Oja SS, Marnela KM, Leino E, Paakkonen L. Effects of taurine treatment on epileptic patients. Prog Clin Biol Res 1980; 39: 157-66.
43. Mongiovi A. Clinical study on the control of epilepsy using taurine. Rev Neurol 1978; 48: 305-25.
44. Kleinrok AT, Zaczkiewicz A, Tomaszewski A, Gorny D, Billewicz-Stankiewicz J. The influence of taurine on acetylcholine content and synthesis in rat brain. Pol J Pharmacol Pharm 1980; 32: 313-7.
45. Csernansky JG, Bardgett ME, Sheline YI, Morris JC, Olney JW. CSF excitatory amino acids and severity of illness in Alzheimer's disease. Neurology 1996; 46: 1715-20.
46. Ikeda H. Effects of taurine on alcohol withdrawal. Lancet 1977; 2: 509.
47. Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 1996; 347: 1438-42.
48. Wilde MI, Wagstaff AJ. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 1997; 53: 1038-53.
49. Guérin P, Ménézo Y. Hypotaurine and taurine in gamete and embryo environments: de novo synthesis via the cysteine sulfinic acid pathway in oviduct cells. Zygote 1995; 3: 333-43.
50. Meizel S, Lui CW, Working PK, Mrsny RJ. Taurine and hypotaurine: their effects on motility, capacitation and the acrosome reaction of hamster sperm in vitro and their presence in sperm and reproductive tract fluids of several mammals. Dev Growth Differ 1980; 22: 483-94.
51. Legge M, Sellens MH. Free radical scavengers ameliorate the 2-cell block in mouse embryo culture. Human Reprod 1991; 6: 867-87.